Minerva Neurosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.
CEORémy Henri Luthringer
CEORémy Henri Luthringer
Employees8
Employees8
HeadquartersBurlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded2007
Founded2007
Employees8
Employees8
NERV Key Statistics
Market cap26.16M
Market cap26.16M
Price-Earnings ratio-2.02
Price-Earnings ratio-2.02
Dividend yield—
Dividend yield—
Average volume55.57K
Average volume55.57K
High today$3.80
High today$3.80
Low today$3.27
Low today$3.27
Open price$3.27
Open price$3.27
Volume35.95K
Volume35.95K
52 Week high$12.46
52 Week high$12.46
52 Week low$1.15
52 Week low$1.15
Stock Snapshot
Minerva Neurosciences(NERV) stock is priced at $3.80, giving the company a market capitalization of 26.16M. It carries a P/E multiple of -2.02.
As of 2025-12-04, Minerva Neurosciences(NERV) stock has fluctuated between $3.27 and $3.80. The current price stands at $3.80, placing the stock +16.2% above today's low and 0.0% off the high.
Minerva Neurosciences(NERV) shares are trading with a volume of 35.95K, against a daily average of 55.57K.
In the last year, Minerva Neurosciences(NERV) shares hit a 52-week high of $12.46 and a 52-week low of $1.15.
In the last year, Minerva Neurosciences(NERV) shares hit a 52-week high of $12.46 and a 52-week low of $1.15.
People also own
Based on the portfolios of people who own NERV. This list is generated using Robinhood data, and it’s not a recommendation.